5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione
CAS: 2784-27-2
Ref. 3D-FH131980
1g | To inquire | ||
2g | To inquire | ||
5g | To inquire | ||
10g | To inquire | ||
500mg | To inquire |
Product Information
- 2,4-imidazolidinedione
- 5-(4-hydroxyphenyl)-5-phenyl-
- (Hydroxyphenyl)phenylhydantoin
- (p-Hydroxyphenyl)phenylhydantoin
- 2,4-Imidazolidinedione, 5-(4-hydroxyphenyl)-5-phenyl-
- 2,4-Imidazolidinedione, 5-(4-hydroxyphenyl)-5-phenyl- (9CI)
- 4-Hydroxydiphenylhydantoin
- 4-Hydroxyphenytoin
- 5-(4-Hydroxyphenyl)-5-phenyl hydantoin
- 5-(4-Hydroxyphenyl)-5-phenyl-2,4-imidazolidinedione
- See more synonyms
- 5-(p-Hydroxyphenyl)-5-phenylhydantoin
- 5-Phenyl-5-p-hydroxyphenylhydantoin
- Ccris 7051
- Hpph
- Hydantoin, 5-(p-hydroxyphenyl)-5-phenyl-
- Hydroxydiphenylhydantoin
- Hydroxyphenytoin
- Nsc 156081
- dl-5-(p-Hydroxyphenyl)-5-phenylhydantoin
- p-Hydroxydiphenylhydantoin
- p-Hydroxyphenytoin
- para-Hydroxyphenytoin
5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione (PPI) is a potent inducer of the cytochrome P450 enzyme system. This drug is metabolized to phenytoin, which is used for the treatment of epileptic seizures. PPIs are also used to treat diabetic neuropathy and other conditions. PPIs are potent inducers of the cytochrome P450 enzyme system and can induce hepatic drug metabolism, leading to an increased risk for drug interactions. PPIs have been shown to be effective against hypersensitivity syndrome, human serum albumin, and monoclonal antibody preparations in vitro.
Chemical properties
Technical inquiry about: 3D-FH131980 5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.